Prestige Consumer Healthcare (PBH) FY2016 results: revenue $806 million, up 12.8% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $806 million for fiscal 2016, the year ended 31 March 2016, up 12.8% on the year before. Net income was $100 million, up 27.7%, and diluted earnings per share $1.88. The figures are the company's own, from the 10-K it filed with the SEC on 17 May 2016.
Revenue
$806 million
+12.8% on the year
FY2010FY2016
Operating margin
32.3%
29.0% a year earlier
FY2010FY2016
Net income
$100 million
+27.7% on the year
FY2010FY2016
Diluted EPS
$1.88
+26.2% on the year
FY2010FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
806
715
597
+12.8%
Cost of revenue
339
n/a
n/a
Gross profit
467
406
336
+15.0%
Gross margin
57.9%
56.8%
56.2%
Operating income
260
208
189
+25.4%
Operating margin
32.3%
29.0%
31.6%
Interest expense
85.3
81.3
68.6
+4.9%
Pre-tax income
157
127
102
+23.3%
Income tax
57.3
49.2
29.1
+16.4%
Effective tax rate
36.4%
38.6%
28.6%
Net income
99.9
78.3
72.6
+27.7%
Net margin
12.4%
11.0%
12.2%
Diluted EPS
$1.88
$1.49
$1.39
+26.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
176
156
112
+12.8%
Capital expenditure
3.6
6.1
2.8
-41.5%
Free cash flow
173
150
109
+15.0%
Free cash flow margin
21.4%
21.0%
18.2%
Cash from investing
-223
-805
-58.0
Cash from financing
52.1
643
-41.2
-91.9%
Depreciation and amortisation
23.7
17.7
13.5
+33.5%
Share-based compensation
10.0
6.9
5.1
+43.9%
Dividends paid
0.0
0.0
0.0
Diluted shares, weighted
53m
53m
52m
+0.9%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
744
628
563
+18.6%
Debt
1,625
1,561
934
+4.1%
Other liabilities
579
453
298
+27.8%
Total liabilities and equity
2,949
2,642
1,796
+11.6%
Fixed assets
15.5
13.7
9.6
+13.1%
Goodwill
360
291
191
+23.9%
Intangible assets
2,323
2,135
1,395
+8.8%
Cash and equivalents
27.2
21.3
28.3
+27.7%
Receivables
95.2
87.9
65.0
+8.4%
Inventory
91.3
74.0
65.6
+23.3%
Other assets
36.6
19.7
41.4
+85.8%
Total assets
2,949
2,642
1,796
+11.6%
10-K for the year ended 31 March 2016, filed 17 May 2016: the filing.